BenevolentAI Lead Sheet
Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for BenevolentAI Ltd’s relevant decision makers and contact details.
A sample of BenevolentAI Lead Sheet data
| Lead Date | Lead Type | Lead Description | Company Name | Drug Name | Therapy Area |
|---|---|---|---|---|---|
| 02 May 2022 | GDCTWXYZ | Lorem | Lorem | Lorem | Cardiovascular |
| 25 Apr 2022 | Mergers & Acquisitions | Odyssey Acquisition Merges with BenevolentAI | BenevolentAI Ltd | 10 early discovery programs; Antiviral; Atopic Dermatitis; bavisant dihydrochloride; BEN-2293; BEN-8744; BEN-9160; BEN-XX1; Chronic Kidney Disease; CNS Diseases; Glioblastoma Multiforme; Inflammatory Bowel Disease; Nonalcoholic Steatohepatitis (NASH); Nonalcoholic Steatohepatitis (NASH) 1; Oncology; Oncology 1; Oncology 2; Parkinsons disease; Small Molecule 2 for Amyotrophic Lateral Sclerosis; Small Molecule for Congestive Heart Failure; Small Molecule for Systemic Lupus Erythematosus; Small Molecule for Unspecified Infectious Diseases | Cardiovascular; Central Nervous System; Dermatology; Gastrointestinal; Genito Urinary System And Sex Hormones; Immunology; Infectious Disease; Oncology; Undisclosed |
| 25 Apr 2022 | Mergers & Acquisitions | Odyssey Acquisition Merges with BenevolentAI | Odyssey Acquisition S.A. | 10 early discovery programs; Antiviral; Atopic Dermatitis; bavisant dihydrochloride; BEN-2293; BEN-8744; BEN-9160; BEN-XX1; CNS Diseases; Glioblastoma Multiforme; Nonalcoholic Steatohepatitis(NASH); Nonalcoholic Steatohepatitis(NASH) 1; Oncology; Oncology 1; Oncology 2; Small Molecule 2 for Amyotrophic Lateral Sclerosis; Small Molecule 2 for Ulcerative Colitis; Small Molecule for Unspecified Infectious Diseases | Central Nervous System; Dermatology; Gastrointestinal; Infectious Disease; Oncology; Undisclosed |
| 12 Apr 2022 | Rescue Study | This company may need services for their Phase I/II trial Completion | BenevolentAI Ltd | BEN-2293 | Dermatology |
Feature
Lead Sheet offers business development users in a Supplier Company, convenient access to leads within the biopharmaceutical industry.
- Lead: Any current or future events that signal a company may need services from another company in the near future.
Depending on the user’s company type, specific events may be considered a lead for the goods or services they provide.
Benefit
Leads within Lead Sheet fall into six major types of occurrences: Trial Events, Regulatory Events, Deals, Insights, New Companies, and Role Changes.
Some of these categories are broken out further to allow users the flexibility to filter to the event types they consider a lead.
Any lead type starting with “Expected” implies that it is a future event sourced from our Catalyst Calendar.
Value
Lead Sheet is a business development tool to help optimize sales efficiency
- What prospective accounts to target
- When and why to target them through actionable leads/opportunities
- Who to reach out to
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward